Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07236099 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 34 → 43 locationsv5
  2. Trial sites expanded: 16 → 34 locationsv4
  3. Study sites: 15 to 16v3
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Nov 2025 to Nov 27, 2025v2 Show 1 more changeShow less
    • Start date changed from estimate of Nov 2025 to Nov 27, 2025
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
Trial Details
NCT Number NCT07236099
Lead Sponsor Beijing InnoCare Pharma Tech Co., Ltd.
Conditions Prurigo Nodularis (PN)
Enrollment 135 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov